209 related articles for article (PubMed ID: 23992851)
21. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia.
Steenhoff AP; Shah SS; Ratner AJ; Patil SM; McGowan KL
Clin Infect Dis; 2006 Apr; 42(7):907-14. PubMed ID: 16511752
[TBL] [Abstract][Full Text] [Related]
22. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):253-7. PubMed ID: 20224541
[TBL] [Abstract][Full Text] [Related]
23. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
[TBL] [Abstract][Full Text] [Related]
24. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine.
Mera R; Miller LA; Fritsche TR; Jones RN
Microb Drug Resist; 2008 Jun; 14(2):101-7. PubMed ID: 18491947
[TBL] [Abstract][Full Text] [Related]
25. Clinical presentation of invasive pneumococcal disease in Spain in the era of heptavalent conjugate vaccine.
de Sevilla MF; García-García JJ; Esteva C; Moraga F; Hernández S; Selva L; Coll F; Ciruela P; Planes AM; Codina G; Salleras L; Jordan I; Domínguez A; Muñoz-Almagro C
Pediatr Infect Dis J; 2012 Feb; 31(2):124-8. PubMed ID: 22173137
[TBL] [Abstract][Full Text] [Related]
26. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
Parra EL; De La Hoz F; Díaz PL; Sanabria O; Realpe ME; Moreno J
Vaccine; 2013 Aug; 31(37):4033-8. PubMed ID: 23680440
[TBL] [Abstract][Full Text] [Related]
27. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.
Huang SS; Platt R; Rifas-Shiman SL; Pelton SI; Goldmann D; Finkelstein JA
Pediatrics; 2005 Sep; 116(3):e408-13. PubMed ID: 16140686
[TBL] [Abstract][Full Text] [Related]
28. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine.
Hendrickson DJ; Blumberg DA; Joad JP; Jhawar S; McDonald RJ
Pediatr Infect Dis J; 2008 Nov; 27(11):1030-2. PubMed ID: 18845981
[TBL] [Abstract][Full Text] [Related]
29. The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.
Ampofo K; Pavia AT; Chris S; Hersh AL; Bender JM; Blaschke AJ; Weng HY; Korgenski KE; Daly J; Mason EO; Byington CL
Pediatr Infect Dis J; 2012 Mar; 31(3):228-34. PubMed ID: 22330164
[TBL] [Abstract][Full Text] [Related]
30. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Oct; 56(41):1077-80. PubMed ID: 17947966
[TBL] [Abstract][Full Text] [Related]
31. Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy.
Ansaldi F; de Florentiis D; Canepa P; Zancolli M; Martini M; Orsi A; Durando P; Icardi G
Vaccine; 2012 Mar; 30(13):2288-94. PubMed ID: 22306795
[TBL] [Abstract][Full Text] [Related]
32. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
Farrell DJ; Klugman KP; Pichichero M
Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
[TBL] [Abstract][Full Text] [Related]
33. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT
Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758
[TBL] [Abstract][Full Text] [Related]
34. Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta.
Leal J; Vanderkooi OG; Church DL; Macdonald J; Tyrrell GJ; Kellner JD
Pediatr Infect Dis J; 2012 Sep; 31(9):e169-75. PubMed ID: 22673137
[TBL] [Abstract][Full Text] [Related]
35. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.
Kaplan SL; Barson WJ; Lin PL; Romero JR; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Mason EO
Pediatr Infect Dis J; 2013 Mar; 32(3):203-7. PubMed ID: 23558320
[TBL] [Abstract][Full Text] [Related]
36. Changes in nasopharyngeal carriage and serotype distribution of antibiotic-resistant Streptococcus pneumoniae before and after the introduction of 7-valent pneumococcal conjugate vaccine in Hong Kong.
Ho PL; Chiu SS; Chan MY; Ang I; Chow KH; Lau YL
Diagn Microbiol Infect Dis; 2011 Dec; 71(4):327-34. PubMed ID: 22000087
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007.
Ardanuy C; Tubau F; Pallares R; Calatayud L; Domínguez MA; Rolo D; Grau I; Martín R; Liñares J
Clin Infect Dis; 2009 Jan; 48(1):57-64. PubMed ID: 19035779
[TBL] [Abstract][Full Text] [Related]
38. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.
Pilishvili T; Lexau C; Farley MM; Hadler J; Harrison LH; Bennett NM; Reingold A; Thomas A; Schaffner W; Craig AS; Smith PJ; Beall BW; Whitney CG; Moore MR;
J Infect Dis; 2010 Jan; 201(1):32-41. PubMed ID: 19947881
[TBL] [Abstract][Full Text] [Related]
39. Prevenar experience.
Arguedas A; Soley C; Abdelnour A
Vaccine; 2011 Sep; 29 Suppl 3():C26-34. PubMed ID: 21896350
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
